AI readiness in pharma: Getting the foundation right
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
BC Platforms brings agentic AI to real-world data
A notable focus of the article is the AI “black box” problem, the difficulty of understanding how AI models generate specific outputs and reproducing those results. This is precisely where BC Catalyst demonstrates its strength. By combining genomic, clinical, real-world data from our global data partner network and inputs from public sources in an agentic AI model that continues to learn and grow, it fuels precision medicine strategy, market access, and evidence generation.
The article is available behind a paywall: https://www.signifyresearch.net/signify-premium-insights/spi-digital-laboratory-bc-platforms-brings-agentic-ai-to-real-world-data/
BC Catalyst: Your research starts here
Discover an intuitive AI-powered platform that accelerates evidence generation across the entire drug lifecycle.
Last updated